Showing posts with label heart disease. Show all posts
Showing posts with label heart disease. Show all posts

Thursday, August 21, 2014

Thousands Sue for Damages Against Cholesterol Drugs as Big Pharma Defends Billion Dollar Industry

August 20, 2014
Brian Shilhavy
Source: Health Impact News Daily

 The $100 billion dollar cholesterol-lowering statin drug industry is under attack, as thousands of Americans are filing lawsuits against the manufacturers of cholesterol-lowering drugs such as Lipitor.

Research continues to confirm just how dangerous these drugs are, with yet another study published recently linking increased statin drug use to type 2 diabetes. Since the study was published by the American Diabetes Association, these known risks to cholesterol-lowering drugs can no longer be denied or defended, and the lawsuits are pouring in at a rapid pace. Most of the lawsuits at this point are from women who have suffered with diabetes as a result of taking cholesterol-lowering drugs, but lawsuits over breast cancer, Alzheimer’s, liver damage, and others may soon follow now that it is generally known how dangerous these drugs are.

This information regarding a tsunami of lawsuits against cholesterol drug manufacturers has yet to be widely published by the mainstream media, however. To find out the magnitude of the lawsuits being filed against statin drug manufacturers, we turn to law firms who are reaping the fruit of litigation against Big Pharma.

According to statistics supplied by various law firms, there were 464 claims filed against Lipitor as of April 15, 2014, which increased to 703 by May 15, and then to 846 by June 16. As of mid-July 2014 over 959 claims have been filed for damages due to Lipitor alone. There are also many claims currently filed against Crestor, the next nearest competitor to Lipitor, and undoubtedly other similar drugs now sold under generic labels. These lawsuits now number well over 1,000, and are increasing at a rapid pace.

Lipitor is  by far the most profitable drug in the history of mankind among all pharmaceutical products, let alone being the most profitable cholesterol drug before its patent expired at the end of 2011. Sales to date from this one particular cholesterol-lowering statin drug has exceeded $140 billion.

Lipitor benefited from the change in marketing laws in 1997 that allowed pharmaceutical companies in the U.S. to advertise their products directly to consumers. Pfizer convinced an entire generation of Americans that they needed a pill to lower their cholesterol in order to prevent heart disease, in what will go down as one of the most brilliant and unethical marketing schemes of all time.

After Lipitor’s patent expired at the end of 2011, the FDA issued its first warnings against statin drugs, which includes: liver injury, memory loss, diabetes, and muscle damage. Soon after issuing these warnings, the lawsuits started trickling in. Today, with more and more studies being published linking statin drug use to various side effects, those lawsuits have become a tidal wave, even though you are not likely to hear about this in the mainstream media.

Big Pharma Fights Back – They Do Not Want you to Know Cholesterol Drugs are Worthless and Dangerous

As is often the case when learning about the criminal activities of Big Pharma, much of the research is conducted outside of the U.S. The above referenced study published recently by the American Diabetes Association, for example, was conducted in Italy. 

Since the patent on Lipitor has expired, pharmaceutical companies have been searching for the next big blockbuster cholesterol drug to bring in profits like Lipitor did. One of these newer cholesterol-lowering drugs is U.S.-made Zetia by Merck. Alberto Donzelli, head of education, appropriateness, and evidence-based medicine at Milan’s public health authority in Italy, has issued warnings about the dangers of this drug, and advised doctors in Italy not to prescribe it. Merck responded with two cease-and-desist orders and the threat of suing Donzelli. Donzelli backed down, but Merck has received a lot of public pressure in Europe since the story was picked up by the British Medical Journal. It was also reported in the Wall Street Journal here in the U.S. When doctors and medical professionals oppose Big Pharma, they put their careers and sometimes their lives on the line.

dr maryanne demasi Thousands Sue for Damages Against Cholesterol Drugs as Big Pharma Defends Billion Dollar Industry
Dr MaryAnne Demasi from the Catalyst. Her investigative reporting on the dangers of statin drugs has now been banned in Australia.

The fact that cholesterol is not responsible for heart disease, and that cholesterol-lowering drugs provide no statistical advantages to prolonging life by reducing heart attacks, has been widely reported for many years now by those of us in the alternative health media. One mainstream media source in Australia, however, decided to air a documentary on the Cholesterol Myth and “Cholesterol Drug Wars”. The show featured Dr. MaryAnne Demasi and interviewed several doctors and health officials who dared to tell the truth regarding the cholesterol drug scam. It was broadcast by ABC Australia in late 2013, under vigorous protests from the pharmaceutical industry. The videos were eventually removed from their website, and the network issued a statement retracting their endorsement of the show. However, they can still be seen on YouTube for now (watch them here.)

What’s Next in the Cholesterol Drug Wars?

One in four Americans over the age of 45 are currently on statin drugs. In spite of the increased research linking these drugs to diabetes, Alzheimer’s Disease, liver damage, breast cancer, among many others (see: Consumer Alert: 300+ Health Problems Linked To Statin Drugs), government-funded Big Pharma agencies continue to promote statin drugs and are attempting to get more Americans to take them. New guidelines put out by the American Heart Association earlier this year (2014) would more than double the number of Americans taking statin drugs. Big Pharma educated doctors and health officials have been so indoctrinated by the cholesterol theory of heart disease, that there have actually been debates about adding cholesterol lowering drugs to drinking water! In their minds, every person on the planet should be taking these cholesterol-lowering drugs.

However, as we are seeing, Americans are starting to wake up to the Cholesterol Myth and the Statin Drug scam, and those injured by these drugs are seeking damages in litigation at a very fast pace here in 2014, in spite of the mainstream media blackout due to intimidation from Big Pharma.
So what’s next?

If we follow the pattern of Big Pharma when their products can no longer be supported in a free market due to lack of consumer confidence and demand, and massive litigation due to faulty products, they will probably seek some kind of government protection from these lawsuits. Such government protection will allow them to distribute their cholesterol drugs through government drug programs such as Medicare and Medicaid, and the new Obamacare. With the baby boomer generation heading into their senior years, it is just too large of a market for them to give up without a fight.
The logic they will use with politicians in Washington D.C. will be very similar to the logic currently used by the vaccine market: Americans are too stupid to know better, so we need laws to protect us and our products against litigation so we can continue to manufacture and distribute them to people who don’t want them, because they don’t realize how much they need our drugs.

This logic is clearly seen in the above referenced American Diabetes study on statins, where they state in their conclusion: “Benefits of statins in reducing cardiovascular events clearly overwhelm the diabetes risk.” In other words, we need to sacrifice those who are harmed by our products for “the greater good” of society, because our drugs are necessary for public health.

This kind of logic and legal protection against their dangerous products is exactly what happened in 1986, when Big Pharma convinced Congress that vaccines were necessary for public health, in spite of the fact that they were causing great harm and sales were slumping, while they were incurring great legal bills in litigation. They threatened Congress to stop manufacturing vaccines due to all the litigation, and Congress obliged by passing legislation that removed all legal liability for damages due to vaccines. That law was then upheld years later, in 2011, by the U.S. Supreme Court. Today, you cannot sue Big Pharma for damages due to their vaccines, which has resulted in the U.S. administering more vaccines per child than any other country in the world. Without legal protection, the industry would not have survived. Or if it had survived, we would have far fewer and far safer vaccines in the marketplace today. Instead, we mass vaccinate with an ineffective annual flu vaccine that is crippling hundreds of people a year (see: Government Pays Damages to Vaccine Victims: Flu Shot Most Dangerous with GBS and Death Settlements). The flu shot is being mandated for certain segments of the population as a condition for employment or school, with increasing pressure to mandate forced vaccinations for a greater segment of the population all in the name of “public health safety”.

Is this kind of government protection and mandated drug distribution on the horizon for cholesterol-lowering drugs? You can be sure they will try. It is up to you, the consumer, to stop buying their products now, and to stop voting for people to represent you in Washington D.C. who support Big Pharma.

We are currently living in the Dark Ages when it comes to health freedom, as today’s pharmaceutical companies are the biggest criminals in the marketplace, having reached settlements in criminal medical abuses that reach into the billions of dollars. Yet the government continues to not only recommend their products, but purchase and distribute them with YOUR tax dollars via government funded programs such as Medicare, Medicaid, and Obamacare.

As a  consumer, you must resist purchasing these toxic products, and fight against any kind of mandated “health program” that forces you to purchase or take their products. History will look back on these Dark Days of medical tyranny with horror. In the meantime, don’t become a fatality and statistic to the cholesterol drug scam! If you are responsible for caring for any seniors, help them to not become a fatality or statistic as well, by being informed and taking a stand for your rights!

References

Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study – Diabetes Care
FDA Expands Advice on Statin Risks – FDA.gov
MSD Italy is criticised for threatening legal action over prescription advice to GPs – British Medical Journal
Merck Threatened to Sue Doc Over Prescribing Advice – Wall Street Journal
Two Studies Suggest Risk of Diabetes with Statins Such As Crestor – LawyersandSettlements.com
Lipitor Lawsuits Continue to Be Filed in South Carolina Litigation – Benzinga.com

More on the Cholesterol Myth

More on the Statin Scam

 Link: http://healthimpactnews.com/2014/thousands-sue-for-damages-against-cholesterol-drugs-as-big-pharma-defends-billion-dollar-industry/.

 

The Cholesterol Drug War: ABC Australia Bans Documentary Exposing Statin Drug Scandal


August 20, 2014 
Source: Health Impact News Daily
 
Health Impact News Editor Comments

Dr. MaryAnne Demasi’s documentary on the criminal activity of the pharmaceutical industry regarding cholesterol-lowering statin drugs sent shock waves through the mainstream media in Australia last year. Published in two parts on the popular news show The Catalyst, the pharmaceutical industry complained loudly after the first show, and requested the network not air the second episode, “Heart of the Matter Part 2 – Cholesterol Drug War.”

ABC Australia aired it anyway, but the pharmaceutical influence is apparently too strong, as it was announced that the network would remove the videos from their website because “they breached its impartiality standards.” They also removed them from YouTube.

These two episodes were among the most watched videos on Health Impact News in 2013, with tens of thousands of “likes” on Facebook alone, helping the videos go viral outside of Australia.
We found other copies on YouTube for now, but it may only be a matter of time before YouTube bans these altogether. If you or anyone you know have been prescribed cholesterol-lowering statin drugs, then you need to watch this documentary. It could save your life.

Here are the two episodes, with our original commentary:

Outside of the United States, the myth that saturated fat and cholesterol cause heart disease is quickly falling apart. Sweden just recently became the first western nation to reject the low-fat dietary philosophy in favor of a high-fat low-carbohydrate diet. A leading cardiologist in the U.K. made shock waves recently by appearing in the mainstream media and stating that saturated fats were not the cause of heart disease, but refined carbohydrates were.

Now, ABC TV in Australia has released a news documentary with the title: “HEART OF THE MATTER: The Cholesterol Myth: Dietary Villains and Cholesterol Drug War.” This documentary interviews cardiologists, science writers, and other experts who expose the saturated fat and cholesterol myth. This is part 1 of a 2-part series.

Part 1 caused so much controversy when it was aired (watch it below), that Australia’s top medicine safety expert, Emily Banks, urged the ABC not to air the follow-up, because it might encourage people to go off their anti-cholesterol statin drugs. “If people stop using their statins . . . it’s very likely that it will result in death,” she said. (Source.)

Wow, talk about scare tactics! If the science that is represented in this documentary is wrong, why not refute the science instead of using scare tactics to endorse censorship? Fortunately, ABC Australia did not censor it, and you can watch Part 2 here.

People around the world are waking up to these dietary myths, as well as the scam of cholesterol-lowering drugs and how harmful they actually are. But given how much of a threat exposing this myth is in losing billions of dollars in profits in the United States, will the mainstream media and the U.S. Government follow other western nations? Those of us in the alternative media, via the Internet, have been covering this issue for more than a decade now!


ABC News in Australia has done an incredible investigative report on cholesterol-lowering statin drugs, daring to expose organized crime in the pharmaceutical industry in the U.S. This is an area where no mainstream media outlet in the USA dares to go, due to the influence of the pharmaceutical industry.
 
In this excellent investigative documentary, cardiologists are interviewed to reveal the fraud of cholesterol-lowering statin drugs, and the criminal activity that has allowed this class of drug to become the best-selling class of drugs all-time.

After ABC Australia aired Part 1,  The Heart of the Matter, Australia’s top medicine safety expert, Emily Banks, urged ABC not to air the follow-up, because it might encourage people to go off their anti-cholesterol statin drugs. “If people stop using their statins . . . it’s very likely that it will result in death,” she said.

But those scare tactics and attempts at censorship failed, and below is Part 2 as it was aired in Australia, and is now available for the world to watch via the ABC TV Catalyst YouTube channel. Some of the top cardiologists in the U.S. have stated that there is not one single study showing that people who take statins will actually live longer. This fraud is now coming out into the open.

If you or someone you know are prescribed a cholesterol-lowering statin drug, you would do well to invest 30 minutes of your time to watch this investigative report. You are not likely to learn this information from your doctor, and it could literally change your life.

Link: http://healthimpactnews.com/2014/the-cholesterol-drug-war-abc-australia-bans-documentary-exposing-statin-drug-scandal/.



 
 

Wednesday, June 25, 2014

Why I've ditched statins for good

23 Mar 2014
 By


As experts clash over proposals that millions more of us take statins to prevent heart disease and stroke, a vascular surgeon explains why he feels better without them 

  When I had a routine health check-up eight years ago, my cholesterol was so high that the laboratory thought there had been a mistake. I had 9.3 millimoles of cholesterol in every litre of blood — almost twice the recommended maximum. 

 It was quite a shock. The GP instantly prescribed statins, the cholesterol-lowering drugs that are supposed to prevent heart disease and strokes. For eight years, I faithfully popped my 20mg atorvastatin pills, without side effects. Then, one day last May, I stopped. It wasn’t a snap decision; after looking more closely at the research, I’d concluded that statins were not going to save me from a heart attack and that my cholesterol levels were all but irrelevant.
When I informed my GP of my decision three months later, I wasn’t entirely honest. Rather than say I was sceptical about the drugs, I told my doctor I’d quit the statins because they were causing pain in my arm.
He didn’t bat an eyelid. Evidence from the drug industry published this month – evidence I suspect was heavily reliant on data from the drug industry, as Dr James Le Fanu pointed out on these pages last week – may suggest that side effects are uncommon, but previous studies have found that one in five people on statins suffers adverse side effects, from muscle pain and diarrhoea to memory loss and blurred vision.
The GP simply suggested I try another brand of statin. The sooner the better, he said, given that I’d already been off my prescription for three months. “Hang on,” I said. “Could you give me a blood test first?” When the results came back, he was amazed that my total blood cholesterol was lower than when I’d been on statins. After three months without the pills, it was 5.4mmol/l (5.4 millimoles per litre of blood) compared with 5.7 mmol/l a year earlier.

 The only major changes I’d made to my lifestyle since coming off statins were eliminating sugar (including alcohol and starchy foods such as bread) and eating more animal fat. Many experts now believe that sugar is emerging as a true villain in the heart-disease story; while after decades of demonisation, saturated fat has been acquitted of causing heart disease by a recent “meta” analysis of 70 studies by Cambridge University.

Typically, I was eating red meat three or four times a week and enjoying butter, full-fat milk and plenty of eggs. You would have thought that after three months on a diet so high in saturated fat, my cholesterol would have shot back up to pre-statin levels — but no, it came down and has stayed down seven months on. Not only that, but my levels of LDL (so-called bad cholesterol) were also lower than when I’d been on statins, and my ratio of HDL (so-called good cholesterol) to LDL was under four for the first time, an excellent sign, according to medical wisdom.

Not that I cared about any of this.

Yes, it was the statins that originally reduced my cholesterol levels so dramatically. But so what? I believe that high cholesterol has been a scapegoat for too long. Yes, it may, in some circumstances, be an indicator of heart disease but there is no evidence of a causal link. In my view, high total blood cholesterol or high LDL levels no more cause heart attacks than paramedics cause car crashes, even though they are present at the scene.

Just lowering cholesterol with drugs without sorting out the dietary and lifestyle factors that actually cause heart disease is nonsensical. Besides, there are plenty of other, more reliable indicators of heart-disease risk. What further astonished my GP was that on these indicators I was now apparently better off in other ways than when I’d been on statins. My blood pressure was down. For the first time in years, I was slimmer, especially around the belly. My triglycerides — a type of blood fat with a causal link to heart disease — were lower than at any time in the preceding eight years. My fasting blood glucose was at the optimum level, whereas a year earlier it had been too high. My total white blood count — a marker of inflammation — was lower.

My blood test for a marker called glycated haemoglobin (A1c), high levels of which are associated with heart disease and overall mortality, were bang on normal. Finally, my level of c-reactive protein (CRP) — a protein that rises in response to inflammation — was extremely low. So, biochemically, I was in excellent shape, better than when I’d been on the statins. “Have you taken up running?” asked my bemused GP.

No, I’d always run. For years, I’d exercised three times a week, eaten plenty of fish, refrained from smoking and tried to keep my stress levels low. The only thing I’d changed was my intake of sugar and animal fat.

That check-up was seven months ago and now, at 58, I’m not on a single tablet. My GP is happy. I feel better than I have in years and, at the same time, deeply concerned about proposals advising even wider use of statins.

Until 2005, statins were prescribed only to those with at least a 30 per cent or greater risk of having a heart attack within 10 years. This was then reduced to a 20 per cent risk. Now, draft NHS guidelines would have them dished out to those with just a 10 per cent risk — in other words, most men over the age of 50 and most women over the age of 60.

I am a vascular surgeon. Before founding a private clinic in Dorset 11 years ago, specialising in varicose veins, I worked in the NHS for 13 years. Back then, I didn’t question medical guidance on cholesterol, and thought statins were a wonder drug. And so they probably are, for men who have heart disease — not necessarily because they lower cholesterol, but because they may cut other risks such as the inflammation-marker CRP. Exercise, weight loss and omega 3 supplements also lower CRP.

But what about other groups — women, the elderly and people like me who have not been diagnosed with heart disease? The evidence that we will benefit from cholesterol-lowering drugs is ambiguous at best. The 2011 Hunt 2 study, one of the most recent and largest, followed 52,000 men and women in Norway aged 20-74 with no pre-existing heart disease, for 10 years.

The results for women were crystal clear. The lower a woman’s total cholesterol, the greater her risk of dying, either of heart disease or anything else, including cancer. This reflects findings in previous studies.

For men, high cholesterol was associated with heart disease and death from other causes. But so, too, was low cholesterol — below 5mmol/l. Again, this is only an association, not a causal link. A range of between 5mmol/l and 7mmol/l was the optimum level. Guess what? This is already the national average. In addition, numerous studies have linked high cholesterol levels with increased longevity in the elderly.

As for me, I have not been diagnosed with heart disease, and nobody in my family has had a heart attack. However, all four of my paternal uncles and my sister have diabetes. Research from Canada, published last year in the BMJ, has shown that statins raise the risk of diabetes, so that gives me little faith. The controversy over these drugs was reignited last week when Prof Sir Rory Collins from Oxford University warned that doctors’ hesitancy about prescribing them to those at risk could cost lives.

GPs are, by definition, generalists. They don’t have time to read and analyse data from every paper on every medical condition. Even so, in a recent survey by Pulse magazine, six in 10 GPs opposed the draft proposal to lower the risk level at which patients are prescribed statins. And 55 per cent said they would not take statins themselves or recommend them to a relative, based on the proposed new guidelines.

If that doesn’t speak volumes, I don’t know what does.